Investigator's Brochure (IB) Table

Drugs

Drug Name Drug Company Sort descending IB Date Risk List Available?
ABT-267, ABT 333, ABT-450 and Ritonavir AbbVie June 2017
Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) - New AbbVie December 2018
Tenofovir Gel CONRAD January 2013
Tenofovir Vaginal Ring CONRAD August 2017
Tenofovir Alafenamide/Elvitegravir - New CONRAD July 2019
HEC Placebo Gel CONRAD September 2011
Sofosbuvir/Velapatasvir (Epclusa) Gilead July 2016
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences December 2016 YES
Dapivirine (Microbicide Gel) International Partnership for Microbicides May 2017
Dapivirine (Vaginal Ring) International Partnership For Microbicides July 2018
Bedaquiline (TMC207) Janssen Research & Development February 2019
Etravirine (TMC125, Intelence) Janssen Research & Development April 2018
Rilpivirine (TMC278, Edurant) - New Janssen Research & Development July 2019
Vorinostat (Zolinza) Merck August 2013
Doravirine (MK-1439) - New Merck May 2019
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) - New Merck May 2019
Raltegravir (Isentress) Merck September 2017 YES
Delamanid (OPC-67683) Otsuka April 2019
PC-1005 Population Council April 2017
Cemiplimab (REGN2810) - New Regeneron Pharmaceuticals, Inc. May 2019

Vaccines

Vaccine Name Vaccine Company IB Date Risk List Available?
BG505 SOSIP.664 gp140 - New DAIDS/NIAID/NIH August 2019
B63521^11 gp120 - New DAIDS/NIAID/NIH July 2019
MPER-656 Liposomes with Aluminum Hydroxide Suspension DAIDS/NIAID/NIH February 2019
PGDM1400 Beth Israel Deaconess Medical Center August 2018
PGT121 Beth Israel Deaconess Medical Center January 2019
RSV 6120/DeltaNS2/1030s LID/NIAID/NIH March 2019
CH505TF gp120 Transient DAIDS/NIAID/NIH December 2018
GEO-D02 and MVA-HIV62B Vaccine - New GeoVax June 2019
SAR441236 Sanofi June 2018
10-1074 Rockerfeller University/Mass Biologics October 2018
PDPHV-201401 Laboratory of Nucleic Acid Vaccines (LNAV) October 2017
ALVAC-HIV (vCP2438) Sanofi Pasteur August 2017
AIDSVAX B/E Global Solutions for Infectious Diseases March 2016
Ad26.ENVA.01 Crucell Holland BV June 2013
Bivalent Subtype C gp120 with Aluminum Hydroxide Adjuvant NIAID/NIH June 2015
RSV DeltaNS2-Delta1313-I1314L LID/NIAID/NIH February 2019
Bivalent Subtype C gp120/AS01B GlaxoSmithKline July 2016
rVSV HIV Vaccines Profectus BioSciences January 2016
Bivalent Subtype C gp120/MF59 GlaxoSmithKline July 2016
IHV01 - New Profectus BioSciences Inc. March 2019